Caris Life Sciences Inc (CAI)

NASDAQ · Biotechnology

21.17
-0.46 (-2.13%)
Updated Aug 18, 6:02 PM ET
AI Rating
Buy
Overall Score
65
Trend
75
Momentum
88
Risk
18

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Caris Life Sciences Inc is trading at $21.17, down 2.13% on the session. The 50 day average sits at $17.77 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 67.6, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $17.50 with resistance near $23.66, so that band frames the current range. Average daily movement is roughly $1.12, or about 5.3% of the share price, which is what any stop placement has to allow for. The overall health score of 65 out of 100 combines a trend score of 75, momentum of 88 and a risk score of 18.

Technical indicators

RSI (14)
67.6
strong
MACD
1.492
bullish crossover
SMA 20
18.04
SMA 50
17.77
SMA 200
--
unknown
ATR (14)
1.12
avg daily range
Support
17.50
Resistance
23.66
Volume vs 20d
0.81x
below average
Volatility
90.6%
annualised
1 month
+32.28%
3 months
+42.95%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.